HSC Exam Practice

Sample response. A prediction in population genetics is a scientifically supported expectation based on the evidence available and stated assumptions, expressed using probability or trend language rather than as a guaranteed outcome.

Marking notes. 1 mark for "evidence-based expectation"; 1 mark for explicit recognition of assumptions and/or probability framing (i.e. distinguishes prediction from certainty).

Sample response. Three reliably predicted patterns are: (i) risk patterns in groups or families (e.g. carrier-screening estimates for autosomal recessive conditions); (ii) allele distribution trends within and between populations (e.g. ABO blood-group frequencies); and (iii) broad relatedness trends between populations inferred from sequencing or DNA profiling.

Marking notes. 1 mark per correctly named pattern type. Accept alternative valid descriptors (e.g. inheritance ratios from Punnett squares as a Mendelian prediction).

Sample response. Phenotype is shaped by genotype interacting with environmental factors (such as nutrition, temperature and exposure history), by interactions between genes, and by chance during development. As a result, the same genotype can produce different phenotypes in different individuals or in different environments — most clearly illustrated by monozygotic twins who share a genome yet can differ in phenotype. Genotype alone therefore does not determine phenotype with certainty.

Marking notes. 1 mark for identifying environment as a contributor; 1 mark for identifying gene interactions / other genes / chance; 1 mark for explicit conclusion that genotype alone is not sufficient for exact prediction.

Sample response. A risk pattern describes an increased relative likelihood of a condition in a defined group, supported by population-level evidence — for example, BRCA1 carriers face approximately a 70% lifetime breast-cancer risk. A certain outcome would be a guaranteed result for every individual in the group, which population data does not support; 100% certainty is rarely justified by population genetic evidence.

Marking notes. 1 mark for defining risk pattern as group-level probability / relative likelihood; 1 mark for contrasting this with an unjustified guarantee at individual level.

Sample response. Future predictions require assumptions about mutation, selection, drift, migration, environmental change and reproduction. Each of those forces can alter allele frequencies over time, and small changes in assumed values produce large divergence in long-run projections. The present state can be measured directly from large-scale sequencing data, but the future state must be projected forward, so uncertainty compounds with time.

Marking notes. 1 mark for naming at least two relevant evolutionary forces / assumptions; 1 mark for explaining that present can be measured but future must be projected under assumptions; 1 mark for explicit recognition that uncertainty grows with time.

Sample response. Module 5 explains how heredity works and how inheritance patterns can be predicted from genetic data. Module 6 then extends this framework by examining how mutation, biotechnology and human intervention can alter, modify or further investigate those inherited patterns.

Marking notes. 1 mark for characterising Module 5 (heredity, inheritance, prediction); 1 mark for characterising Module 6 (mutation, biotechnology, intervention) and signalling that Module 6 extends rather than replaces Module 5.

Sample response (a). HbS allele frequency varies markedly across the five regions, from 0.01 (East Asia) and 0.02 (Northern Europe) at the low end, to 0.06 (Mediterranean) and 0.08 (South Asia) at intermediate levels, and 0.15 in Sub-Saharan Africa at the high end. The highest-frequency region carries the allele at approximately 15 times the level seen in East Asia, indicating a substantial population-level difference in allele distribution.

Sample response (b). Reliable conclusion: HbS allele frequency is substantially higher in Sub-Saharan Africa than in East Asia or Northern Europe — this is a clear allele distribution trend supported by large-scale sequencing. Unreliable conclusion (from this data alone): we cannot predict whether any individual in Sub-Saharan Africa will or will not carry the allele or will or will not be affected by sickle-cell disease, nor can we infer causation (e.g. malaria selection) without further evidence.

Sample response (c). Population-level conclusions are strong because they are built from many sequenced individuals, so random sampling noise averages out and the underlying trend emerges robustly. Individual outcomes, by contrast, are shaped by genotype and environment, gene interactions and chance, so the same population trend can produce a wide range of individual phenotypes. The strongest defensible conclusions therefore match the level of evidence — population trends at population level, with cautious wording at the individual level.

Marking notes. (a) 2 marks: 1 for identifying the high-to-low pattern; 1 for citing at least two supporting figures from the data. (b) 2 marks: 1 for a defensible "reliable" conclusion at the population level; 1 for a defensible "unreliable" conclusion at the individual / causal level. (c) 3 marks: 1 for identifying that population trends are averaged across many samples; 1 for identifying that individual outcomes depend on environment, gene interactions and chance; 1 for explicit "match wording to level of evidence" judgement.

Sample response. Module 5 develops a complete framework for predicting inheritance patterns in populations, but the framework itself signals where prediction is strong and where it is not. Mendelian inheritance models give reliable predictions of expected genotype and phenotype ratios in offspring of known crosses: a Cc × Cc cross for cystic fibrosis predicts a 1 : 2 : 1 ratio per pregnancy, and this expectation is empirically robust over many families even though no individual pregnancy is guaranteed to produce exactly that ratio. Non-Mendelian patterns (co-dominance, incomplete dominance, multiple alleles, sex-linkage) extend the same predictive logic to more complex inheritance, e.g. the ABO blood group system. DNA sequencing then scales these predictions up. Single-nucleotide polymorphism analysis identifies high-confidence pathogenic variants such as BRCA1 mutations, and large-scale datasets generated by next-generation sequencing characterise allele frequencies across millions of individuals — for example, the carrier frequency of CFTR mutations is approximately 1 in 25 in European-ancestry populations. DNA profiling supports identification and relatedness inference, including human ancestry trends from mitochondrial DNA. These population-level conclusions — risk patterns, allele distributions, relatedness trends — are the strengths of the Module 5 framework. Limits arise at the individual scale and at long timescales. BRCA1 carriers have a substantially elevated lifetime breast-cancer risk (around 70%), but approximately 30% of carriers do not develop the disease — phenotype depends on environment, modifier genes and chance, as Lesson 12 made explicit. Monozygotic twins sharing an entire genome can differ in phenotype for many traits and diseases. Predictions of future population states also depend on assumptions about mutation, selection, drift and migration; small changes in those assumptions produce very different long-run projections, even when the present allele frequency is known precisely. The overall extent of the framework is therefore context-dependent. At the level of populations and the present, Module 5 supports strong, evidence-based predictions worded with probability and trend language. At the level of specific individuals or distant future populations, predictions carry irreducible uncertainty that strong Biology answers acknowledge rather than hide. This positions Module 6, which extends the framework into how mutation and biotechnology can alter and investigate these inherited patterns further.

Marking notes. 1 mark — recognises that population-level patterns (risk, distribution, relatedness) are predicted reliably. 1 mark — uses a named Mendelian / non-Mendelian example correctly (e.g. CFTR cross, ABO). 1 mark — invokes sequencing / SNP / profiling evidence appropriately (Lessons 16–17). 1 mark — invokes large-scale population data (Lesson 18) and gives at least one quantitative figure (e.g. CFTR carrier frequency, HbS, BRCA1 risk). 1 mark — gives a clear example of an uncertain prediction (e.g. BRCA1 individual outcome, identical twin divergence). 1 mark — explains why uncertainty exists (environment + gene interactions + chance + assumptions for future projections; links to Lesson 12 gene–environment interaction). 1 mark — explicit context-dependent judgement that rewards strong wording at population level and cautious wording at individual / future-state level. 1 mark — uses precise terminology (allele frequency, SNP, Hardy–Weinberg, autosomal recessive, prediction, uncertainty) and signals the Module 5 → Module 6 handoff.